Learn more about the HyProCure® procedure and how it is the permanent solution for talotarsal displacement and hyperpronation. Narrated by Dr. Michael E. Graham, podiatric surgeon and inventor of HyProCure®.
The first true talotarsal stabilization device, anatomically designed to permanently correct partial talotarsal dislocation (TTDS). If you are suffering from foot, ankle, leg, knee, or hip pain, or even flat feet, you may be experiencing the effects of Partial TaloTarsal Dislocation Syndrome (TTDS). To learn more about TTDS, visit http://www.hyprocure.com/. Find a HyProCure® trained doctor in your area at http://hyprocure.com/doctorlocator.php
Saturday, October 27, 2012
Friday, October 26, 2012
Will there be a visible scar after my HyProCure® procedure?
The incision is less than an inch long and slender and this part of the skin heals remarkably well. With time, the scar should become virtually invisible, in most cases.
Learn more at www.HyProCure.com
Learn more at www.HyProCure.com
Thursday, October 18, 2012
Tuesday, October 16, 2012
Monday, October 15, 2012
Sunday, October 14, 2012
New EOTTS Classification System Identifies HyProCure® as Having Better Design and Patient Outcomes
A recent study, Extra-Osseous Stabilization Devices: A New Classification System published in The Journal of Foot and Ankle Surgery, Volume 51, Issue 5, Pages 613-619, September 2012, provides a systematic approach to classifying the differences in design features and biomechanical function of Extra-Osseous TaloTarsal Stabilization (EOTTS) devices.
Read more >>>
To read the abstract of this study and find further research on the positive outcomes of EOTTS with HyProCure® visit the library section of http://www.GraMedica.com/.
Read more >>>
To read the abstract of this study and find further research on the positive outcomes of EOTTS with HyProCure® visit the library section of http://www.GraMedica.com/.
Friday, October 12, 2012
HyProCure® Stabilization Procedure Proven Effective in Restoring Normal Range of Motion
The Journal of Foot & Ankle Surgery recently published a study on radiographic outcomes following the correction of talotarsal displacement using HyProCure® in adult patients. The article, Surgical Treatment of Hyperpronation Using an Extra-Osseous TaloTarsal Stabilization Device: Radiographic Outcomes in Adult Patients, JFAS Volume 51, Issue 5, Pages 548-555, September 2012, indicated a stabilization of the talotarsal joint complex and elimination of hyperpronation, which may lead to reduced pain, improved foot function and high levels of patient satisfaction.
Read More >>>
Read More >>>
Tuesday, October 9, 2012
Young Patient Says HyProCure® was Life- Changing
23-year-old patient from Ottawa, Canada shares her journey from suffering with chronic pain to finding a life-changing solution.
View her two videos and a clip from her surgeon at http://hyprocure.com/patient-testimonials/testimonials-adult/.
View her two videos and a clip from her surgeon at http://hyprocure.com/patient-testimonials/testimonials-adult/.
Saturday, October 6, 2012
Leading Chinese Foot and Ankle Surgeon Bestowed Title of GIII® 2012 “Game Changer”
The Game Changer Award is an esteemed recognition given by GIII® and GraMedica® to an individual who demonstrates a strong dedication and passion to improve the quality of life for patients suffering from the ill-effects of foot pathologies and who helps elevate the field of foot and ankle surgery.
GIII® and GraMedica® are pleased to recognize Dr. Zhang for his hard work and will continue to support his future endeavors to educate Chinese foot and ankle specialists on the treatment of foot and ankle conditions.
Read more.
GIII® and GraMedica® are pleased to recognize Dr. Zhang for his hard work and will continue to support his future endeavors to educate Chinese foot and ankle specialists on the treatment of foot and ankle conditions.
Read more.
Friday, October 5, 2012
Chinese Surgeons Trained in use of HyProCure® at 2012 TongRen Foot and Ankle Symposium
Specialists in attendance at China’s leading Foot and Ankle Symposium gained valuable education on the Extra-Osseous TaloTarsal Stabilization Procedure.
“The room was packed with surgeons, all with their cameras and video cameras, eager for their first foot cadaver course,” said Michael E. Graham, DPM, FACFAS, FAENS, founder of GraMedica® and creator of HyProCure®. “It was amazing to be involved in such a ground-breaking event.” Read more.
“The room was packed with surgeons, all with their cameras and video cameras, eager for their first foot cadaver course,” said Michael E. Graham, DPM, FACFAS, FAENS, founder of GraMedica® and creator of HyProCure®. “It was amazing to be involved in such a ground-breaking event.” Read more.
Thursday, October 4, 2012
Changing Lives, One Step at a Time: HyProCure® Marks 8 Years
Over the past eight years, HyProCure®, a Type II Extra-Osseous TaloTarsal Stabilization (EOTTS) device, has become the leading solution for patients suffering with the symptoms and secondary conditions resulting from partial talotarsal dislocation. TaloTarsal Displacement is a foot imbalance that throws both the foot and the entire body out of alignment. It affects people of all ages and is often the direct or contributing cause of overpronation, bunions, plantar fasciitis, knee pain, hip pain, back pain, and even problems in the neck and shoulders. Read more.
Creator of HyProCure® Educates Foot & Ankle Specialists Across China
In a recent journey throughout China, innovator of the life changing HyProCure® procedure took time to educate surgeons, meet with patients and share his skills. Read more.
Subscribe to:
Posts (Atom)